Advertisement

PharmacoEconomics

, Volume 9, Issue 4, pp 283–285 | Cite as

Cost Considerations in the Drug Treatment of Hypertension

Is Older Better?
  • Norman M. Kaplan
Current Opinion Cost in Treating Hypertension
  • 7 Downloads

Keywords

Diltiazem Calcium Antagonist Joint National Committee Texas Southwestern Medical Calcium Antagonist Diltiazem 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Holme I, Ekelund LG, Hjermann I, et al. Quality—adjusted meta—analysis of the hypertension/coronary dilemma. Am J Hypertens 1994; 7: 703–12PubMedGoogle Scholar
  2. 2.
    Kaplan NM. Measurement of the blood pressure. In: Kaplan NM, editor. Clinical hypertension. 6th ed. Baltimore: Williams and Wilkins, 1994: 23–45Google Scholar
  3. 3.
    Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881–4PubMedCrossRefGoogle Scholar
  4. 4.
    Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure: the fifth report of the Joint National Committee on Detection. Evaluation, and Treatmentof High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154–83CrossRefGoogle Scholar
  5. 5.
    Johannesson M. Economic evaluation of hypertension treatment Textbook of hypertension. Oxford: Blackwell Scientific Publications, 1994: 1292–302Google Scholar
  6. 6.
    Hilleman DE, Mohiuddin SM, Lucas Jr BD, et al. Cost—minimization analysis of initial anti—hypertensive therapy in patientswith mild—to—moderate essential diastolic hypertension. Clin Ther 1994: 16: 88–102PubMedGoogle Scholar
  7. 7.
    Kaplan NM. Cost—effectiveness of anti—hypertensive drugs: fact or fancy? Am J Hypertens 1991; 4: 478–80PubMedGoogle Scholar
  8. 8.
    Selar DA, Tessier GC, Skaer TL, et al. Effect of pharmaceutical formulation of diltiazem on the utilization of medicaid andhealth maintenance organization services. Curr Ther Res 1994; 55: 1136–49CrossRefGoogle Scholar
  9. 9.
    SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolatedsystolic hypertension: final results of the Systolic Hypertensionin the Elderly Program (SHEP). JAMA 1991; 265: 3255–64CrossRefGoogle Scholar

Copyright information

© Adis International Limited 1996

Authors and Affiliations

  • Norman M. Kaplan
    • 1
  1. 1.University of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations